AAAAAA

   
Results: 1-11 |
Results: 11

Authors: Krausz, Y Ikeda, DM Jadvar, H Langleben, D Birdwell, R Strauss, HW
Citation: Y. Krausz et al., Non-visualization of sentinel lymph node in patients with breast cancer, NUCL MED C, 22(1), 2001, pp. 25-32

Authors: Orfanos, SE Psevdi, E Stratigis, N Langleben, D Catravas, JD Kyriakidis, M Moutsopoulos, HM Roussos, C Vlachoyiannopoulos, PG
Citation: Se. Orfanos et al., Pulmonary capillary endothelial dysfunction in early systemic sclerosis, ARTH RHEUM, 44(4), 2001, pp. 902-911

Authors: Sebbag, I Rudski, LG Therrien, J Hirsch, A Langleben, D
Citation: I. Sebbag et al., Effect of chronic infusion of Epoprostenol on echocardiographic right ventricular myocardial performance index and its relation to clinical outcome in patients with primary pulmonary hypertension, AM J CARD, 88(9), 2001, pp. 1060

Authors: Khoury, J Langleben, D
Citation: J. Khoury et D. Langleben, Heparin-like molecules inhibit pulmonary vascular pericyte proliferation in vitro, AM J P-LUNG, 279(2), 2000, pp. L252-L261

Authors: Langleben, D Schlesinger, R
Citation: D. Langleben et R. Schlesinger, Differentiation between mitral stenosis and coexisting PPH - Reply, THORAX, 55(9), 2000, pp. 808-808

Authors: Langleben, D Lamoureux, E Marcotte, F Schlesinger, R Dragatakis, L Crowe, MJ Langlois, Y Lemire, F White, M
Citation: D. Langleben et al., Mitral stenosis obscuring the diagnosis of plexogenic pulmonary arteriopathy and familial pulmonary hypertension, THORAX, 55(3), 2000, pp. 247-248

Authors: Orfanos, SE Armaganidis, A Glynos, C Psevdi, E Kaltsas, P Sarafidou, P Catravas, JD Dafni, UG Langleben, D Roussos, C
Citation: Se. Orfanos et al., Pulmonary capillary endothelium-bound angiotensin-converting enzyme activity in acute lung injury, CIRCULATION, 102(16), 2000, pp. 2011-2018

Authors: Badesch, DB Tapson, VF McGoon, MD Brundage, BH Rubin, LJ Wigley, FM Rich, S Barst, RJ Barrett, PS Kral, KM Jobsis, MM Loyd, JE Murali, S Frost, A Girgis, R Bourge, RC Ralph, DD Elliott, CG Hill, NS Langleben, D Schilz, RJ McLaughlin, VV Robbins, IM Groves, BM Shapiro, S Medsger, TA Gaine, SP Horn, E Decker, JC Knobil, K
Citation: Db. Badesch et al., Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease - A randomized, controlled trial, ANN INT MED, 132(6), 2000, pp. 425

Authors: Dupuis, J Langleben, D Stewart, DJ
Citation: J. Dupuis et al., Pulmonary hypertension, EN CEL RE S, 5, 1999, pp. 267-282

Authors: Langleben, D Barst, RJ Badesch, D Groves, BM Tapson, VF Murali, S Bourge, RC Ettinger, N Shalit, E Clayton, LM Jobsis, MM Blackburn, SD Crow, JW Stewart, DJ Long, W
Citation: D. Langleben et al., Continuous infusion of epoprostenol improves the net balance between pulmonary endothelin-1 clearance and release in primary pulmonary hypertension, CIRCULATION, 99(25), 1999, pp. 3266-3271

Authors: Orfanos, SE Langleben, D Khoury, J Schlesinger, RD Dragatakis, L Roussos, C Ryan, JW Catravas, JD
Citation: Se. Orfanos et al., Pulmonary capillary endothelium-bound angiotensin-converting enzyme activity in humans, CIRCULATION, 99(12), 1999, pp. 1593-1599
Risultati: 1-11 |